Interaction of gliclazide and rifampicin.
Kihara
Y
Y
Otsuki
M
M
D000368:Aged; D000904:Antibiotics, Antitubercular / Q000097:blood / Q000627:therapeutic use*; D017291:Clarithromycin / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy*; D004347:Drug Interactions; D004359:Drug Therapy, Combination / Q000627:therapeutic use*; D004977:Ethambutol / Q000627:therapeutic use; D005907:Gliclazide / Q000097:blood / Q000627:therapeutic use*; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D007004:Hypoglycemic Agents / Q000097:blood / Q000627:therapeutic use*; D007538:Isoniazid / Q000627:therapeutic use; D008297:Male; D009165:Mycobacterium Infections, Nontuberculous / Q000150:complications / Q000188:drug therapy*; D009170:Nontuberculous Mycobacteria; D012293:Rifampin / Q000097:blood / Q000627:therapeutic use*
D000904:Antibiotics, Antitubercular; D017291:Clarithromycin; D004977:Ethambutol; D005907:Gliclazide; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D007538:Isoniazid; D012293:Rifampin